Sodium acetate attenuates ulcerative colitis by reducing intestinal epithelial apoptosis and remodeling gut microbiota
Frontiers in Microbiology · 20.08.2026 · 17
DOI: 10.3389/fmicb.2026.1888741 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Microbiology, online erschienen am 20.08.2026. Verfasst von Qinxin Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, The Affiliated Hospital of Qingdao University, Qingdao, China. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Sodium acetate (NaA), an acetate donor among short-chain fatty acid salts, is involved in intestinal epithelial homeostasis, mucosal inflammation, and host–microbiota interactions. However, its role in ulcerative colitis (UC), particularly in regulating epithelial apoptosis and gut microbiota remodeling, remains unclear. This study investigated the protective effects and potential mechanisms of NaA in experimental colitis.
Methods
LPS-induced intestinal epithelial cell injury models using NCM460 and Caco-2 cells, together with a DSS-induced mouse colitis model, were established to evaluate the effects of NaA in vitro and in vivo . Cell viability was assessed using the CCK-8 assay. Colonic histopathology and mucus production were examined by H&E and AB/PAS staining. Immunohistochemistry, Western blotting, RT-qPCR, and ELISA were performed to detect barrier-related proteins, inflammatory cytokines, and apoptosis-associated molecules. Gut microbiota alterations were analyzed by 16S rRNA amplicon sequencing.
Results
NaA showed no obvious cytotoxicity within an appropriate concentration range and increased ZO-1 and Occludin expression in intestinal epithelial cells. Under LPS stimulation, NaA restored barrier protein expression and reduced the BAX/BCL-2 ratio and cleaved-caspase-3 expression in both NCM460 and Caco-2 cells. In DSS-induced colitis mice, NaA alleviated body weight loss, disease activity index elevation, colon shortening, and spleen index increase. NaA also attenuated colonic histological injury, increased AB/PAS-positive areas, restored ZO-1, Occludin, and MUC2 expression, and reduced IL-6, TNF- α , and IL-1β levels. Moreover, NaA inhibited excessive epithelial apoptosis. 16S rRNA amplicon sequencing and analysis showed that NaA partially reversed DSS-induced gut microbiota dysbiosis, as reflected by improved microbial diversity and community structure, increased Firmicutes/Bacteroidota ratio, reduced Bacteroides and Turicibacter abundance, and enrichment of potential beneficial genera, including Bifidobacterium , Lactobacillus , and Blautia .
Conclusion
NaA alleviates experimental colitis by suppressing inflammation, inhibiting excessive epithelial apoptosis, preserving epithelial tight-junction and mucus barrier integrity, and partially restoring gut microbiota homeostasis. These findings suggest that acetate-based intervention may be a potential strategy for UC management through coordinated regulation of epithelial protection and microbial remodeling.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Zitieren
APA
Liu, Q., Han, R., Wang, Y., Mao, T., Qi, X., Cao, B., Tian, Z., & Li, Y. (2026). Sodium acetate attenuates ulcerative colitis by reducing intestinal epithelial apoptosis and remodeling gut microbiota. Frontiers in Microbiology, 17. https://doi.org/10.3389/fmicb.2026.1888741
Vancouver
Liu Q, Han R, Wang Y, Mao T, Qi X, Cao B, et al. Sodium acetate attenuates ulcerative colitis by reducing intestinal epithelial apoptosis and remodeling gut microbiota. Frontiers in Microbiology. 2026;17. doi:10.3389/fmicb.2026.1888741
BibTeX
@article{Liu2026,
author = {Liu, Qinxin and Han, Rongshuang and Wang, Yi and Mao, Tao and Qi, Xingsi and Cao, Bin and Tian, Zibin and Li, Yukun},
title = {Sodium acetate attenuates ulcerative colitis by reducing intestinal epithelial apoptosis and remodeling gut microbiota},
journal = {Frontiers in Microbiology},
year = {2026},
volume = {17},
doi = {10.3389/fmicb.2026.1888741}
}
EUVIMED